Cell Bank of Epstein Barr Virus Specific Cytotoxic T Lymphocytes

Clinical trial NCT01823718 · UNKNOWN

Trial details

NCT number: NCT01823718
Sponsor: Nantes University Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

EBV Associated Lymphoma

Start date: 2007-02-01
Primary completion: 2014-08-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.